Trademark: 86921653
Status Date
Monday, February 12, 2018
Filing Date
Friday, February 26, 2016
Published for Opposition
Tuesday, May 16, 2017
Abandoned Date
Monday, February 12, 2018
44 Medical testing and analysis services in the field of cancer research and disease classification through the genomic analysis of rare blood cells and other biological specimen types, namely, providing clinical and medical laboratory tests that detect gene expression and mutations associated with cancer, the evaluation of such tests, and information in the fields of cancer screening, diagnosis and treatment, all for diagnostic or treatment purposes
Mar 6, 2018
Undeliverable Mail - Corresp. Remailed
Feb 12, 2018
Abandonment Notice Mailed - No Use Statement Filed
Feb 12, 2018
Abandonment - No Use Statement Filed
Jul 11, 2017
Noa E-Mailed - Sou Required From Applicant
May 16, 2017
Official Gazette Publication Confirmation E-Mailed
May 16, 2017
Published For Opposition
Apr 26, 2017
Notification Of Notice Of Publication E-Mailed
Apr 11, 2017
Law Office Publication Review Completed
Apr 6, 2017
Approved For Pub - Principal Register
Mar 24, 2017
Teas/Email Correspondence Entered
Mar 24, 2017
Correspondence Received In Law Office
Mar 16, 2017
Assigned To Lie
Mar 6, 2017
Notice Of Revival - E-Mailed
Mar 6, 2017
Teas Response To Office Action Received
Mar 6, 2017
Petition To Revive-Granted
Mar 6, 2017
Teas Petition To Revive Received
Jan 9, 2017
Abandonment Notice Mailed - Failure To Respond
Jan 9, 2017
Abandonment - Failure To Respond Or Late Response
Jun 10, 2016
Notification Of Non-Final Action E-Mailed
Jun 10, 2016
Non-Final Action E-Mailed
Jun 10, 2016
Non-Final Action Written
Jun 10, 2016
Assigned To Examiner
Mar 2, 2016
New Application Office Supplied Data Entered In Tram
Mar 1, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
